The Role of Radiofrequency Ablation in the Management of Benign and Malignant Breast Lesions

The management of breast lesions encompasses a comprehensive clinical spectrum ranging from benign tumors like fibroadenomas to early-stage breast cancer. Conventional treatments, including radiotherapy and surgical excision—continue to be fundamental, although they may cause major morbidity, cosmetic compromise, and psychological discomfort. Recently, there has been an increased interest in image-guided ablation techniques in minimally invasive, organ-preserving therapies. Radiofrequency ablation (RFA) has started to be a reasonable intervention for various breast lesions. Emphasizing its utility, clinical effectiveness, safety, and comparative advantages over other ablative techniques, this review aims to assess the role of RFA in controlling benign and malignant breast diseases. Specific attention is directed toward patient selection criteria, oncological results, aesthetic satisfaction, and modern imaging technology integration. Current studies, particularly in small and welldefined lesions, show that RFA is effective in obtaining high local control rates and patient satisfaction. Current studies, particularly in small and well-defined lesions, show that RFA is effective in obtaining high local control rates and patient satisfaction. Although long-term survival and recurrence data remain limited, RFA may be highly suitable for nonsurgical candidates with early-stage breast cancer. Although RFA has emerged as a promising technique, its integration into clinical practice requires further validation through cost-effectiveness studies and randomized controlled trials. The results support RFA's prospective application in enhancing customized, minimally invasive intervention for breast lesions.